A study of Rohitakadi Vati in management of type-2 Diabetes Mellitus.

Clinical evaluation of Rohitakadi Vati in Prameha with special reference to type-2 Diabetes Mellitus – a Randomized placebo-controlled trial. - Nill

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065998

Enrollment

100

Registered

2024-04-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Confirmed diagnosis of type-2 diabetes mellitus according to American Diabetes Association criteria. 2) Fasting glucose level between 125 to 200 mg/dL, Post prandial blood sugar level 200 to 280 mg/dL. 3) HbA1c level between 6.4 to 7.5 %.

Exclusion criteria

Exclusion criteria: 1) Type-1 diabetes mellitus 2) Gestational diabetes 3) Patient with type 2 diabetes mellitus below age 30 years and above age 60 years. 4) Patients with fasting sugar more than 200 mg/dL and post prandial more than 280 mg/dL will be excluded from study. 5) Pregnancy or breastfeeding. 6) History of severe diabetic complications, such as diabetic ketoacidosis. 7) Patients with history of severe liver, kidney or heart disease. 8) Patients having any other life threatening disease.

Design outcomes

Primary

Measure	Time frame
Fasting Blood Sugar (FBS) Post Prandial Blood Sugar (PPBS) Glycosylated Hb (HbA1c) Urine Sugar Timepoint: 90 days	—

Secondary

Measure	Time frame
Polyuria, Polydipsia, Polyphagia, Tiredness, Hyperhidrosis, Dryness of mouth, Burning sensation in Hands & Feet.Timepoint: Every 15 days for 90 days	—

Countries

India

Contacts

Public ContactDr Mohit Pandit

Shree Saptashrungi Ayurved Mahavidyalay and Hosptal, Nashik

somdattak85@gmail.com9860268117

Outcome results